Vimian Group AB (publ)
SSE:VIMIAN.ST
29.12 (SEK) • At close February 20, 2024
Overzicht | Financiële gegevens
Bedrijfsnaam | Vimian Group AB (publ) |
Symbool | VIMIAN.ST |
Munteenheid | SEK |
Prijs | 29.12 |
Beurswaarde | 12,936,268,800 |
Dividendpercentage | 0% |
52-weken bereik | 20.08 - 37.96 |
Industrie | Diagnostics & Research |
Sector | Healthcare |
CEO | Mr. Alireza Tajbakhsh |
Website | https://vimian.com |
An error occurred while fetching data.
Over Vimian Group AB (publ)
Vimian Group AB (publ) engages in the animal health business worldwide. It operates through Specialty Pharma, MedTech, Diagnostics, and Veterinary Services segments. The company offers proprietary diagnostics, prescription, and non-prescription treatments for preventive care and treatment of chronic conditions for companion animals under the Nextmune brand name; and molecular and
Vergelijkbare Aandelen
Financiële Gegevens
Cijfers zijn in miljoenen (SEK)
Cijfers zijn in miljoenen (SEK)